Morgan Stanley’s Evoke Pharma EVOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$166 Hold
64
﹤0.01% 7595
2025
Q1
$176 Buy
64
+33
+106% +$91 ﹤0.01% 7486
2024
Q4
$137 Hold
31
﹤0.01% 7443
2024
Q3
$148 Hold
31
﹤0.01% 7404
2024
Q2
$198 Hold
31
﹤0.01% 7301
2024
Q1
$229 Sell
31
-32
-51% -$236 ﹤0.01% 7302
2023
Q4
$788 Buy
+63
New +$788 ﹤0.01% 7234
2023
Q1
Sell
-1
Closed -$19 7751
2022
Q4
$19 Buy
+1
New +$19 ﹤0.01% 7776
2022
Q3
Hold
0
7747
2022
Q2
Sell
-43
Closed -$3K 7850
2022
Q1
$3K Sell
43
-24
-36% -$1.67K ﹤0.01% 7680
2021
Q4
$5K Sell
67
-721
-91% -$53.8K ﹤0.01% 7639
2021
Q3
$148K Sell
788
-3,258
-81% -$612K ﹤0.01% 6151
2021
Q2
$798K Sell
4,046
-981
-20% -$193K ﹤0.01% 5218
2021
Q1
$1.33M Buy
5,027
+1,527
+44% +$402K ﹤0.01% 4549
2020
Q4
$1.3M Buy
3,500
+2,855
+443% +$1.06M ﹤0.01% 4497
2020
Q3
$436K Buy
645
+461
+251% +$312K ﹤0.01% 4711
2020
Q2
$93K Buy
184
+181
+6,033% +$91.5K ﹤0.01% 5435
2020
Q1
$1K Sell
3
-7
-70% -$2.33K ﹤0.01% 6457
2019
Q4
$2K Hold
10
﹤0.01% 6497
2019
Q3
$1K Sell
10
-53
-84% -$5.3K ﹤0.01% 6542
2019
Q2
$5K Buy
63
+3
+5% +$238 ﹤0.01% 6304
2019
Q1
$13K Sell
60
-48
-44% -$10.4K ﹤0.01% 6120
2018
Q4
$39K Sell
108
-1
-0.9% -$361 ﹤0.01% 5823
2018
Q3
$46K Buy
109
+78
+252% +$32.9K ﹤0.01% 5896
2018
Q2
$11K Hold
31
﹤0.01% 6280
2018
Q1
$9K Sell
31
-6
-16% -$1.74K ﹤0.01% 6282
2017
Q4
$12K Sell
37
-4
-10% -$1.3K ﹤0.01% 6185
2017
Q3
$20K Buy
41
+17
+71% +$8.29K ﹤0.01% 6028
2017
Q2
$9K Sell
24
-34
-59% -$12.8K ﹤0.01% 6262
2017
Q1
$26K Buy
58
+43
+287% +$19.3K ﹤0.01% 6008
2016
Q4
$4K Buy
15
+12
+400% +$3.2K ﹤0.01% 6298
2016
Q3
$1K Buy
+3
New +$1K ﹤0.01% 6417
2015
Q3
Sell
-12
Closed -$9K 6638
2015
Q2
$9K Buy
12
+5
+71% +$3.75K ﹤0.01% 6316
2015
Q1
$7K Hold
7
﹤0.01% 6292
2014
Q4
$6K Buy
+7
New +$6K ﹤0.01% 6297
2014
Q3
Sell
-3
Closed -$4K 6588
2014
Q2
$4K Hold
3
﹤0.01% 6314
2014
Q1
$4K Sell
3
-125
-98% -$167K ﹤0.01% 6273
2013
Q4
$137K Buy
+128
New +$137K ﹤0.01% 5216